Company ProfilePremium

NAOS Emerging Opportunities Company Limited

Company Profile Analysis

Ticker: NCC.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
NAOS Emerging Opportunities Company Limited - Company showcase

Year Founded & Workforce

2012

NAOS Emerging Opportunities Company Limited logo

NAOS Emerging Opportunities Company Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

NAOS Emerging Opportunities Company Limited Overview

NCC is a micro-capitalisation LIC, about A$28m by market value and about A$41m by net assets. It gives investors long-term, highly concentrated exposure to Australian and New Zealand emerging industrial companies, both listed and unlisted, and excludes resources. It typically holds zero to 20 positions (10 at July 2026). More than 90% of the portfolio sits outside the ASX indices, so it diverges sharply from its Small Ordinaries benchmark. The vehicle is externally managed by NAOS Asset Management, a Sydney boutique founded in 2004 that is majority employee- and director-owned and a Certified B Corporation. NAOS also runs two sister LICs, NAC and NSC. NCC uses structural leverage through A$22.8m of convertible notes (NCCGA). It targets a sustainable, fully franked dividend (4.20 cps in FY26). FY26 marked a sharp recovery: +18.72% portfolio return and A$7.1m net profit. This followed a deeply negative FY22–FY24 run, so NCC remains a turnaround and catalyst-driven special situation trading at a material discount to NTA.


Company's own description

In its FY26 Annual Report, NCC states that its principal activity is investing primarily in a concentrated portfolio of listed and unlisted equities. The aim is long-term, concentrated exposure to public and private Australian and New Zealand emerging companies, excluding resource companies [S1]. The objectives, paraphrased from the report, are threefold:

  • provide a sustainable stream of dividends franked to the maximum extent possible;

  • deliver long-term investment performance above the S&P/ASX Small Ordinaries Accumulation Index;

  • maintain a profits reserve that can support dividends in weaker performance years [S1].

The Directors' Report confirms NCC is an LIC that has outsourced its investment management function to NAOS Asset Management [S1].

Business model

NCC raises permanent (closed-end) equity capital and supplements it with fixed-rate convertible note debt (NCCGA). It deploys that capital into a small number of high-conviction positions in emerging industrial companies. Value is created, or destroyed, through four channels:

  1. Capital appreciation of investee companies, realised on exit or recognised as unrealised fair-value gains.

  2. Dividend and interest income from investees. Cash dividends received were A$0.66m in FY26 versus A$1.84m in FY25 [S1].

  3. Tax and franking mechanics. The LIC structure lets NCC pay corporate tax and stream franking credits to shareholders. A sizeable deferred tax asset (A$6.31m at 30 June 2026) reflects carried-forward losses and unrealised positions [S1].

  4. Capital management. NCC buys back NCCGA notes below face value (accretive), purchases DRP shares on-market when the shares trade below NTA (non-dilutive), and issues bonus options [S1][S6].

Revenue model

Revenue componentNatureFY26 evidence
Net gains on financial assets at fair valueRealised and unrealised; the dominant and volatile driverTotal income A$10.33m; cash dividends received A$0.66m, implying gains were the large majority. A line-item split was not captured in the extract reviewed [S1]
Dividend incomeRecurring but smallA$0.66m cash received in FY26 (A$1.84m FY25) [S1]
Interest incomeNegligibleA$1,240 cash received in FY26 [S1]
Product / service / subscription / licensingNot applicableNCC has no operating products or services

Value-chain position, customers and end-markets

NCC sits at the capital-provision layer of the small-cap equity value chain. Its "customers" are its shareholders, mostly retail and self-managed superannuation fund (SMSF) investors; NAOS reports about 5,500 investors across its vehicles [S1]. A second constituency is NCCGA noteholders. Its "end-markets" are the sectors its investees serve. At 2026 these were:

  • engineering and construction for defence, water and energy (Saunders International);

  • building materials distribution (Big River Industries);

  • cloud communications and IT (Comms Group);

  • pharmacy supply-chain software (Pharmx Technologies);

  • AI data-centre infrastructure (Firmus Grid, unlisted);

  • school uniforms and e-commerce (Schoolblazer) [S1][S2].

Independent characterisation

NCC is best understood as a levered, concentrated, activist-leaning micro-cap private-equity-style vehicle in a listed wrapper. Its record is bifurcated:

  • strong early years: FY14 +31.54%, FY16 +24.77%, FY21 +48.34%;

  • a severe drawdown: FY22 −15.14%, FY24 −26.49%;

  • a recovery: FY25 +5.59%, FY26 +18.72% [S2].

The leverage from the convertible notes magnifies both directions. Gross portfolio value of A$62.7m sits against A$22.8m face value of notes, so notes are about 36% of gross assets [S2]. The manager has publicly acknowledged that top-heavy weightings created "opportunity cost" risk. It has committed to increasing the number of holdings and reducing concentration [S1].

Strategy

Stated strategy themes (FY26 Annual Report, paraphrased) [S1]

  1. Concentrated, long-term ownership. Hold 0–20 high-conviction emerging companies with high ROIC and aligned management, and "ignore the index" (more than 90% of the portfolio sits outside ASX indices).

  2. Constructive engagement. Work with investee boards on growth capital, communications, capital management, strategy and board effectiveness, including board seats where appropriate.

  3. Exploit illiquidity. The closed-end structure removes redemption risk and allows holding of less liquid micro-caps.

  4. Circle of competence. Avoid businesses dominated by interest-rate or commodity variables and keep resources excluded.

  5. Sustainable franked dividends. Grow the dividend, supported by a profits reserve.

  6. ESG integration and B Corp values. Negative screens and ESG factor assessment are built into the process.

Strategic initiatives, last 24 months

InitiativeDateDetailSource
Portfolio de-concentrationFY26–FY27The manager commits to increasing holdings and reducing top-heavy weightings, acknowledging that subjective market valuations created opportunity-cost risk[S1]
Exit of OrdermentumFY26Full exit from a ~4-year unlisted holding; capital redeployed[S1]
Dividend increaseFeb 2026Half-yearly dividend lifted from 2.00 to 2.10 cps (+5.0% annual rate)[S1][S3]
NCCGA buy-backFY26 (Jun–Jul 2026 notices)1,705 notes bought back below face and cancelled, reducing interest cost and gearing[S1][S11]
Non-dilutive DRPFY25–FY26All DRP entitlements satisfied by on-market purchases (A$431k in FY26)[S1]
Investor communicationsOngoingMonthly newsletter, weekly "NAOS Insights", quarterly reports and webinars, annual roadshow[S1]
Manager corporate restructure7 Aug 2026NAOS Asset Management converted to a Pty Ltd[S1]
ESG / B CorpOngoingNAOS maintains B Corp certification (subject to periodic recertification) and donates about 1% of revenue[S1]

Medium-term targets and guidance

NCC provides no financial guidance: no earnings, NTA or dividend targets. The FY27 outlook is expressed as investee-level catalysts. The manager states it expects catalysts across the portfolio to emerge over the next 12–18 months [S1]. No cost-reduction programme with quantified targets has been announced.

Products & Services

NCC sells no goods or services. Its "product catalogue" is the set of securities it has issued to investors, plus the investment strategy delivered by its manager.

The NAOS investment universe funnel works as follows [S1]:

  • It starts from 2,203 ASX-listed companies.

  • It removes the ASX Top 50, companies below A$20m market cap and ETFs.

  • It removes companies without substantial revenue, structurally declining industries, negatively screened industries and companies with unsustainable debt.

  • The result is about 312 companies in the NAOS universe and an active watchlist of 41–90 names.

  • NCC holds 0–20 of these.

Product Portfolio

"Product"Description / key termsTarget holderLaunchPricing / costSource

NCC ordinary shares (ASX: NCC)

Closed-end LIC equity; 73,799,601 on issue; half-yearly fully franked dividends; DRP available

Retail, SMSF, high-net-worth investors

Feb 2013

Market-priced; traded at a 21.18% discount to pre-tax NTA at 30 Jun 2026

[S1]

NCCGA convertible notes

Unsecured, unsubordinated, redeemable convertible notes; A$100 face; fixed coupon 4.50% to 30 Sep 2026, 5.50% to 30 Sep 2027, 6.50% to 30 Sep 2028 maturity; conversion at A$1.15/share (about 86.96 shares per note); 2% p.a. penalty-rate clause if leverage exceeds 50% LTV; 228,295 on issue

Income investors

Mar 2021

Traded A$85.10 (Mar 2026) to A$91.00 (Jul 2026) per A$100 face

[S5][S2][S12]

NCCO bonus options

1-for-5 bonus options; exercise A$0.67 on or before 31 Dec 2026; 14,234,845 outstanding

Existing shareholders (issued free)

Dec 2023

Closing price A$0.001 (31 Jul 2026), i.e., deeply out of the money

[S6][S2]

Dividend Reinvestment Plan

Reinvests dividends; shares bought on-market when NCC trades below NTA, so no dilution

Existing shareholders

—

No brokerage

[S1][S2]

Investment strategy (delivered by NAOS)

Concentrated, long-term, engagement-led; 0–20 holdings; excludes resources; negative screens on tobacco, gambling, nuclear/uranium, controversial weapons, coal mining, oil & gas production, animal cruelty

—2,013

1.25% management fee; 20% performance fee with recoupment of prior under-performance

[S1][S2]

Financial Narrative

All figures are in A$ unless stated. FY22–FY24 detail is limited to the five-year summary in the FY26 remuneration report [S1] and aggregator data [S4][S13].

Income statement

Notes on sources and data quality:

  • FY22–FY24 income comes from aggregator S13.

  • NPAT, DPS and franking come from S1. FY25–FY26 line items come from S1. Portfolio returns come from S2.

  • "Other operating expenses" groups administration, directors, ASX, audit, custody, registry and other expenses (FY26: A$574,854; FY25: A$543,473).

  • Gross, operating and EBITDA "margins" are not meaningful for an LIC because income includes mark-to-market gains. NPAT/income was 8.1% in FY25 and 69.1% in FY26.

  • Revenue CAGR is not meaningful because the base years are negative.

Balance sheet

Notes on sources and data quality:

  • Source is S1 (statement of financial position, changes in equity and the five-year table). The FY24 cash figure is the FY25 opening balance.

  • Working capital in the conventional sense is not meaningful; current assets of A$57.8m are almost entirely the investment portfolio.

Cash flow

Sources: FY25–FY26 from S1. FY23–FY24 OCF and financing come from aggregator S4 and are rounded to the nearest A$m.

Ratios

Ratio sources and methods:

  • FY23–FY24 ROE and gearing, and the FY23–FY25 MER and FY25 payout, come from S4.

  • FY25–FY26 ratios are analyst calculations from S1 figures.

  • FY24 net gearing (56.9%) is from S4. The calculation basis is not stated, so it may differ from the analyst method used for FY26.

  • ROIC, current ratio, asset turnover and cash conversion cycle are not meaningful for an LIC and are omitted.

Trend commentary

FY22–FY24: drawdown phase. NCC lost A$12.8m (FY22), A$0.5m (FY23) and A$17.7m (FY24) after tax. Shareholders' equity fell from A$68.0m to A$39.5m. Post-tax NTA dropped from A$0.93 to A$0.54 per share [S1].

The FY24 portfolio return of −26.49% included losses in nine of twelve months, with May 2024 at −7.95% [S2]. The combination of concentrated micro-cap positions and fixed-cost leverage was punishing. The notes carried a fixed A$1.0m+ annual coupon while asset values fell, which pushed net gearing from 32.1% (FY23) to 56.9% (FY24) on aggregator data [S4].

Dividends were cut from 7.50 cps (FY22–FY23) to 5.75 cps (FY24) and then 4.00 cps (FY25), and franking was below 100% in FY22–FY24 [S1].

FY25: stabilisation. The portfolio returned +5.59% but NPAT was only A$0.28m. Tax expense of A$0.87m absorbed most of the A$1.15m pre-tax profit (effective rate about 75%) [S1].

FY26: inflection. Total income almost tripled to A$10.33m (+194%) and PBT rose 585% to A$7.90m. NPAT rose to A$7.14m (EPS 9.67 cps) [S1]. Operating costs were broadly flat (A$2.43m vs A$2.36m), which demonstrates the operating leverage in an LIC with fixed financing costs.

The pre-tax NTA bridge for FY26 [S1] was:

The interest drag (1.40 cps) exceeds the management fee drag (1.00 cps). That shows the cost of the note structure relative to the asset base.

Post-balance-date uplift. After 30 June 2026, an unlisted investee announced a capital raising priced above NCC's carrying value. If applied at balance date, that price would raise the holding's fair value by about A$5.32m before tax, or about 7.2 cps pre-tax on 73.8m shares (analyst calculation). The Company did not name the investee [S1]. The Investment Manager's outlook separately references a July 2026 private funding round at Firmus Grid, NCC's disclosed unlisted holding [S1]. Together with the July 2026 portfolio return of +8.75%, this explains pre-tax NTA rising to A$0.54 at 31 July 2026 [S2].

Profits reserve. The reserve rose to A$24.0m (32.6 cps), roughly 7.8 years of dividends at the 4.20 cps rate (analyst calculation). This underpins the dividend policy despite the accumulated-losses account of −A$61.1m [S1].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it contains"Products / services"

Investment in listed and unlisted emerging-company equities (Australia/NZ, ex-resources)

About 10 investments (July 2026), including 1 private investment; plus an unlisted convertible note held as an asset (Level 3)

Portfolio management outsourced to NAOS; no external products

Results by Segment and Segment Margins & Growth (%)

MetricFY24FY25FY26

Segment income (AUD K)

-19,7583,51710,331

Segment profit before tax (AUD K)

—1,1547,901

Segment net profit after tax (AUD K)

-17,6592847,135

PBT margin on income (%)

—32.876.5

Contribution to total income (%)

100100100

Investee Details

InvesteeCodeListed/UnlistedSector exposureStatus in FY26

Saunders International

SND

Listed

Engineering & construction (energy, water, defence, infrastructure)

Core

Big River Industries

BRI

Listed

Timber and building materials manufacturing/distribution (AU/NZ)

Core

Comms Group

CCG

Listed

Cloud communications / IT managed services

Core

Pharmx Technologies

PHX

Listed

Pharmacy supply-chain EDI / marketplace software

Core

Firmus Grid

—

Unlisted

AI factories / data-centre infrastructure

Core

Schoolblazer (formerly Hancock & Gore)

SBZ (formerly HNG)

Listed

School uniforms / e-commerce platform (UK, AU, NZ)

Core

Ordermentum

—

Unlisted

B2B hospitality ordering marketplace

Fully exited in FY26

Statistic Details

StatisticValue

Number of investments

10

Private (unlisted) investments

1

Weighted investment holding period

57 months

Cash weighting

0.15%

Weighted average market cap of investees

A$832.8m

FY26e EBIT growth (portfolio weighted, NAOS estimate)

3.61%

FY26e EBIT margin (NAOS estimate)

2.40%

FY26e OCF yield post leases

3.75%

FY26e net dividend yield

2.45%

FY26e ROIC

7.61%

FY25 actual net debt (portfolio weighted)

A$1.1m

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total income (AUD K)

-16,420-137-19,7583,51710,331

Management fees (AUD K)

———697735

Performance fees (AUD K)

———00

Interest expense on convertible notes (AUD K)

———1,0351,032

Amortisation on convertible notes (AUD K)

———8787

Other operating expenses (AUD K)

———543575

Profit before tax (AUD K)

———1,1547,901

Income tax expense (AUD K)

———870766

Net profit after tax (AUD K)

-12,796-457-17,6592847,135

EBITDA proxy: PBT + interest + amortisation (AUD K)

———2,2769,021

Basic & diluted EPS (A$ cents)

———0.389.67

Dividends per share declared (A$ cents)

7.507.505.754.004.20

Dividend franking level (%)

755067100100

Investment portfolio return (%)

-15.140.34-26.495.5918.72

Expense line

Expense lineFY2025FY2026

Management fees

697,064735,141

Interest expense on convertible notes

1,035,0001,032,370

Amortisation on convertible notes

87,42187,421

Administration fees

51,25051,250

Directors' remuneration

60,00060,269

ASX fees

62,31258,594

Auditor's remuneration

64,50062,178

Custody fees

40,21514,964

Registry fees

61,42961,429

Other expenses

203,767266,170

Total expenses

2,362,9582,429,786

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Cash & equivalents (AUD K)

——15734883

Financial assets at fair value (AUD K)

———49,47457,677

Deferred tax asset (AUD K)

———6,9746,311

Total assets (AUD K)

———60,20164,149

Short-term debt (AUD K)

———00

Long-term debt: convertible notes at amortised cost (AUD K)

———22,71522,632

Net debt (AUD K)

———22,36822,549

Total liabilities (AUD K)

———23,36023,199

Shareholders' equity (AUD K)

68,02562,09639,50936,84140,950

Goodwill & intangibles (AUD K)

00000

Issued capital (AUD K)

——78,02278,02278,022

Profits reserve (AUD K)

——22,05619,38824,036

Accumulated losses (AUD K)

——-60,570-60,570-61,108

Post-tax NTA per share (AUD)

0.930.850.540.500.55

Pre-tax NTA per share (AUD)

———0.40470.4694

Year-end share price (AUD)

0.830.680.4150.2550.37

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow incl. investment trading (AUD K)

—7,8702,4603,1462,914

Purchases of investments (AUD K)

———17,74524,146

Proceeds from sales of investments (AUD K)

———21,33028,777

Dividends received (AUD K)

———1,837657

Interest paid on convertible notes (AUD K)

———1,0671,033

Capex (AUD K)

00000

Free cash flow = OCF − capex (AUD K)

—7,8702,4603,1462,914

Dividends declared and charged to equity (AUD K)

———2,9523,026

Dividends paid net of DRP (AUD K)

———2,6032,597

On-market purchases for DRP (AUD K)

———352431

Convertible note buy-back (AUD K)

———0151

Share buy-backs (AUD K)

———00

Net financing cash flow (AUD K)

—-6,000-5,000-2,955-3,179

Margin Analysis (%) and Financial Ratios (x)

RatioFY2023FY2024FY2025FY2026

ROE on average equity (%)

-0.7-44.70.718.3

ROA on closing total assets (%)

——0.511.1

Debt / equity (x)

——0.620.55

Net debt / equity, net gearing (%)

32.156.960.755.1

Notes / total assets (%)

——37.735.3

Interest coverage: (PBT + interest + amortisation) / interest (x)

——2.28.7

Net debt / EBITDA proxy (x)

——9.82.5

Management expense ratio, Morningstar (%)

2.43.53.1—

Operating expense ratio ex-interest / avg equity, analyst calc (%)

——3.253.37

Dividend payout on EPS (%)

——1,05343

Discount to pre-tax NTA at year end (%)

——36.9921.18

Components

ComponentA$ per share

30 June 2025 pre-tax NTA

0.4047

Portfolio performance

+0.1311

Management fees

−0.0100

Interest expense

−0.0140

Tax paid

−0.0014

Dividends

−0.0410

30 June 2026 pre-tax NTA

0.4694

Results by Region

RegionFY2024FY2025FY2026

Australia & New Zealand combined income (AUD K)

-19,7583,51710,331

Capital Markets Data (AUD) and Market Valuation

MetricFY2022FY2023FY2024FY2025FY2026

Year-end share price (AUD)

0.830.680.4150.2550.37

Year-end market cap (AUD Mn)

—49.630.618.827.3

Year-end post-tax NTA (AUD)

0.930.850.540.500.55

Price / post-tax NTA (x)

0.890.800.770.510.67

Dividends declared (A$ cents)

7.507.505.754.004.20

Dividend yield on year-end price (%)

9.011.013.915.711.4

Measure by Horizon

HorizonMeasure

1-year to 30 Jun 2026

+45.1%

1-year total shareholder return to 30 Jun 2026 (company figure)

+59.18%, or +64.01% including franking [S1]

1-year to early Oct 2026

About −4% (A$0.40 on 9 Oct 2025 versus ~A$0.385 now; price-only, ex-dividend) [S10]

3-year to 30 Jun 2026

−45.6% (A$0.68 to A$0.37)

4-year to 30 Jun 2026

−55.4% (A$0.83 to A$0.37)

Calendar 2026 YTD

−9.41% (to ~A$0.385) [S10]

52-week range

A$0.255–A$0.470 [S9]

Valuation Multiples

MultipleNCCBasis

P/E (FY26 EPS 9.67c)

~3.9x

S1 EPS. Smallcaps shows TTM 6.80x and annual 100.26x on different bases [S9]

P / post-tax NTA (A$0.60, 31 Jul 2026)

~0.63x

S2.

P / pre-tax NTA (A$0.54, 31 Jul 2026)

~0.70x

S2

EV (mkt cap ~A$28.0m + notes A$22.6m − cash A$0.1m)

~A$50.5m

S1. Gurufocus shows EV A$49.22m at A$0.3625 [S6 context: GuruFocus]

EV / EBITDA proxy (A$9.02m)

~5.6x

Not meaningful for an LIC

EV / Sales (income A$10.33m)

~4.9x

Not meaningful for an LIC

P/B

~0.66–0.68x

S9 and GuruFocus

Dividend History

YearDPS (cps)

2H FY13

2.50

FY14

5.75

FY15

6.25

FY16

6.75

FY17

7.00

FY18

7.25

FY19

7.25

FY20

7.25

FY21

7.50

FY22

7.50

FY23

7.50

FY24

5.75

FY25

4.00

FY26

4.20

Capital Instruments

InstrumentFace (AUD K)CouponStep-upMaturityConversion

NCCGA convertible notes

22,830

4.50% to 30 Sep 2026

5.50% to 30 Sep 2027; 6.50% to 30 Sep 2028

30 Sep 2028

A$1.15 per share

Analyst Conclusions

Management outlook

InvesteeFlagged FY27 catalysts
PharmxMore detail on the value drivers of the Sigma alliance; Sigma's international expansion
SaundersDefence contract wins; water-division expansion outside NSW and Victoria; Sydney Water panel volumes
FirmusFirst AI factory at CDC Melbourne; one to two additional hyperscaler or enterprise contracts (notably Tasmania's Southgate); Indonesian project update; deployment of the July 2026 raise; possible IPO
SchoolblazerDisclosure of three new Australian school wins; progress to a A$25m FY27 EBITDA run-rate, then A$30m; divestment of remaining parent balance-sheet investments to support ~2 cps dividend targets
Big RiverDouble-digit FY27 EBITDA growth target; intentions of the new 19.9% shareholder; further acquisitions; outcome of the Greenstone strategic review

NAOS states that significant latent value remains in the portfolio, that core holdings have materially de-risked, and that catalysts should emerge over 12–18 months. It will also broaden the portfolio and reduce top-heavy weightings [S1]. Investee-level FY27 catalysts flagged [S1]:

Consensus growth expectations: not available, as there is no sell-side coverage.

Bull case

  1. NTA momentum is real and continuing. Pre-tax NTA rose from 40.47c to 46.94c in FY26 and to 54c by July 2026. The unlisted raise alone adds about 7.2c pre-tax [S1][S2].

  2. Multiple catalysts for a discount re-rating. These include the Firmus IPO, Sigma-Pharmx Stage 2 and the Big River review. At about 0.63–0.70x NTA, closing half the discount would add roughly 15–20% (analyst estimate).

  3. Income support. A 4.20 cps fully franked dividend (about 11% cash yield, about 15% grossed up) is backed by 32.6 cps of reserves [S1].

Bear case

  1. Leverage economics are worsening. The coupon steps to 5.5% and then 6.5%, and about A$22.8m is due by September 2028. Repayment may force sales of illiquid holdings at poor prices [S5].

  2. Track record. 3-, 5- and 10-year returns trail the benchmark by 12.58, 7.71 and 5.02 points p.a. [S1]. One strong year does not establish persistence.

  3. Structural sub-scale. About 3.4% of equity in operating costs, plus interest, plus small-LIC illiquidity, can keep the discount entrenched. Concentration and Level 3 valuation risk remain [S1].

Key monitorables, next 12 months

  • Treatment of NCCGA around the September 2026–2028 window: step-up versus redemption or refinancing, and any further buy-backs.

  • Monthly NTA trajectory against A$0.54 pre-tax (July 2026) and the size of the discount.

  • Firmus funding, contracts and IPO.

  • Pharmx Stage 2 milestones.

  • Schoolblazer EBITDA run-rate.

  • Big River strategic review outcome.

  • NCCO expiry (31 Dec 2026).

  • AGM (12 Nov 2026) outcomes, including any board-renewal resolutions.

  • Interim FY27 dividend level (February 2027).

Concluding analyst verdict

NCC enters FY27 in better shape than at any point since FY21. Its FY26 portfolio return of +18.72% beat the benchmark by more than ten points. It earned A$7.1m after tax, rebuilt its profits reserve to 32.6 cents a share, and lifted the dividend for the first time since FY21. Post-balance-date evidence strengthens the picture: a private-round uplift worth about 7 cents pre-tax and an +8.75% July 2026 return took pre-tax NTA to about 54 cents. Meanwhile the shares trade around 38 cents after going ex the 2.1-cent final dividend. On paper, investors buy a concentrated basket of de-risking micro-caps and one AI-infrastructure private holding at roughly a 30% discount, and are paid an 11% franked yield while they wait.

The discount exists for identifiable reasons, however. NCC is structurally small. Its cost base and note coupon absorb close to five cents a share each year before any investment return. Its long-run record remains well behind the benchmark despite the recovery. The convertible notes are the crux. They amplified the FY22–FY24 losses, and their coupon is stepping up. About A$22.8m must be repaid or refinanced by September 2028 from a portfolio of ten mostly illiquid positions. Concentration also cuts both ways, as the FY24 −26.49% year demonstrated.

On balance, NCC is best viewed as a high-risk, catalyst-driven special situation rather than a core small-cap allocation. The asymmetry is favourable if FY27 delivers on even part of the flagged catalysts, especially a Firmus liquidity event and Pharmx monetisation. Those would let the board reduce leverage from strength and narrow the discount. Investors should size positions accordingly. They should treat the NTA discount and the note-refinancing pathway as the two variables that will decide outcomes, and should demand continued evidence of portfolio de-concentration before treating FY26 as a durable inflection rather than a cyclical rebound.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedTenure (to Oct 2026)Prior rolesEducation

Sarah Williams

Independent Chair (Chair since 1 Dec 2022)

31 Jan 2019

~7.7 years

Executive Director at Macquarie Group (Head of IT for asset management, investment banking and leasing); 18 years at Macquarie including leading Risk & Regulatory Change and Equities IT; earlier JP Morgan and PwC London; charity boards (Cure Cancer Australia, Make a Mark Australia). Also Independent Chair of NAC and Independent Director of NSC

Hons Engineering Physics, Loughborough University

Warwick Evans

Non-Independent Director

6 Nov 2012

~13.9 years

MD, Macquarie Equities (global) 1991–2001; Executive Director, Macquarie Group; founding Chairman/CEO of the Newcastle Stock Exchange (NSX); former Chairman of the Australian Stockbrokers Association; Executive Director at County NatWest. Chair of NAOS Asset Management; director of NAC and NSC

B.Com (Economics), UNSW

Sebastian Evans

Non-Independent Director; joint Company Secretary (since 10 Jul 2019)

6 Nov 2012

~13.9 years

CIO and MD of NAOS Asset Management since 2010; CIO across all NAOS strategies; director of NAC and NSC

MAppFin; B.Com; Grad Dip Management (AGSM); Diploma in Financial Services

Roberto Credaro

Independent Director

31 Jan 2025

~1.7 years

Head of Public and Private Equity, Aware Super; CIO, Macquarie Private Bank; Division Director, Macquarie private equity advisory/funds management; earlier Federal Treasury

B.Ec (Hons), Sydney University; CFA; GAICD

Executive Leadership Team

NameRoleJoined NAOSBackground

Sebastian Evans

MD & CIO

CIO since 2010

See above

Robert Miller

Portfolio Manager (all NAOS LICs and NAOS Private Opportunities Fund)

Sep 2009 (PM since Nov 2014)

B.Bus (UTS); MAppFin

Jared Tilley

Senior Investment Analyst

Apr 2021

19+ years; ex-Contact Asset Management, Colonial First State (9 years); CFA

Tom Pearce

Associate Analyst

May 2025

B.Com / B.Adv Studies, University of Sydney

Rajiv Sharma

Chief Business Officer

2017

Lawyer; ex-Magellan, Custom Fleet

Mohit Kabra

Chief Financial Officer

2025

17+ years at Deloitte across three continents; CPA (Colorado); AICPA; associate member ICAI

Angela Zammit

Marketing & Communications Manager

May 2020

Ex-SAI Global, American Express, Citibank

Board of Directors by Director

DirectorEligibleAttended

Sarah Williams

98

Warwick Evans

99

Sebastian Evans

99

Roberto Credaro

99

Directors' Remuneration

DirectorFY2025 total (AUD)FY2026 fees (AUD)FY2026 superannuation (AUD)FY2026 total (AUD)

Sarah Williams

35,00031,3903,76735,157

Warwick Evans

10,0008,9691,07610,045

Roberto Credaro

6,25013,4531,61415,067

David Rickards (to 31 Jan 2025)

8,750000

Total

60,00053,8126,45760,269

Directors' Remuneration (FY2022–FY2026)

MetricFY2022FY2023FY2024FY2025FY2026

Total directors' remuneration (AUD)

60,00060,00060,00060,00060,269

Major Shareholders

HolderShares% of 73.8mDate

Warwick Evans (and related parties)

2,703,5363.66

30 Jun 2026

Sebastian Evans (and related parties)

2,162,1232.93

30 Jun 2026

Sarah Williams

24,8510.03

30 Jun 2026

Roberto Credaro

00.00

30 Jun 2026

NAOS Asset Management Ltd

1,042,0931.41

Date not stated

Total directors

4,690,510

~6.4

30 Jun 2026

Total directors

4,739,384

~6.4

31 Jul 2026

Competitive Landscape

Key Competitors

#PeerCodeManagerPositioning vs NCC
1

WAM Microcap

WMI

Wilson Asset Management

Larger, more diversified micro-cap LIC; strong brand and retail distribution

2

WAM Research

WAX

Wilson Asset Management

Small/mid-cap research-driven; larger scale

3

NAOS Small Cap Opportunities

NSC

NAOS

Sister vehicle; same team; no convertible note per market commentary

4

NAOS Ex-50 Opportunities

NAC

NAOS

Sister vehicle; slightly larger investees; has NACGA notes (175,000 on issue) [S14 context: NAC NTA July 2026]

5

Spheria Emerging Companies

SEC

Spheria / Pinnacle

Small/micro-cap value; more diversified

6

Ryder Capital

RYD

Ryder Investment Management

Concentrated, benchmark-unaware small-cap

7

Thorney Opportunities

TOP

Thorney Investment Group

Concentrated, activist-style micro-cap (status to verify)

8

Sandon Capital Investments

SNC

Sandon Capital

Activist small-cap

9

Acorn Capital Investment Fund

ACQ

Acorn Capital

Listed plus unlisted emerging companies (status to verify)

10

Glennon Small Companies

GC1

Glennon Capital

Small-cap (status to verify)

11

Small-cap ETFs (e.g., Small Ordinaries index ETFs)

various

Passive providers

Low-fee alternative; NCC's manager notes the market "rewards scale and passive index membership" [S1]

Peer Comparison FY2026

MetricNCC (FY26)S&P/ASX Small Ords Accum. (FY26)

1-year portfolio return to 30 Jun 2026

+18.72%+8.11%

3-year p.a. to 30 Jun 2026

−2.69%+9.89%

5-year p.a. to 30 Jun 2026

−4.73%+2.98%

10-year p.a. to 30 Jun 2026

+2.01%+7.03%

Since inception p.a.

+6.26%+5.83%

Management fee

1.25%—

Structural gearing

~35% of total assets (notes)

—

Recent Developments

Upcoming: * roadshow Brisbane (15 Oct), Melbourne (22 Oct), Sydney (27 Oct) and Adelaide (5 Nov); final dividend payment (30 Oct 2026); AGM (12 Nov 2026); NCCO option expiry (31 Dec 2026) [S1][S6].

NCC has no staff.

Company Snapshot

2012

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • FY26 portfolio return of +18.72% beat the benchmark (+8.11%) by 10.61 points [S1].
  • FY26 NPAT of A$7.14m against A$0.28m in FY25 (+2,416%); EPS 9.67 cps [S1].
  • The profits reserve of A$24.0m (32.6 cps) covers about 7.8 years of the 4.20 cps dividend (analyst calculation) [S1].
  • NCC has paid fourteen consecutive years of dividends, with cumulative dividends of 86.45 cps plus 30.33 cps of franking credits [S1].
  • Insider alignment is strong: directors hold about 4.69m shares (~6.4%) and the "Director Alignment" measure is 30.40% [S1][S2].
  • Core holdings have been de-risked. Pharmx gained Sigma Healthcare as a ~10% strategic shareholder and preferred-provider partner, with an A$8.7m fee [S1].

Weaknesses

  • Long-run returns trail the benchmark: 10-year +2.01% p.a. versus +7.03% p.a. [S1].
  • Fixed-coupon leverage: notes of A$22.6m (book) against net assets of A$40.95m, with interest of A$1.03m p.a. exceeding management fees of A$0.74m [S1].
  • Sub-scale cost base: operating expenses excluding interest were about 3.4% of average equity in FY26 (analyst calculation); Morningstar MER was 3.1% in FY25 [S1][S4].
  • Concentration: only 10 holdings, one of them private [S2].
  • Cash buffer is thin: A$83k cash at 30 June 2026 and 0.15% cash weighting at 31 July 2026 [S1][S2].
  • Board independence is only at parity (2 of 4 directors) [S1].

Opportunities

  • Unlisted mark-up: a post-balance-date raise implies about +A$5.32m pre-tax fair-value uplift, about 7.2 cps (analyst calculation) [S1].
  • Firmus IPO and further hyperscaler contracts flagged as FY27 catalysts [S1].
  • Schoolblazer targets: FY27 EBITDA run-rate of A$25m rising to A$30m, and about 2 cps dividend targets at investee level [S1].
  • Big River's strategic review with Greenstone Partners and its new 19.9% corporate shareholder [S1].
  • Narrowing the NTA discount from 21.18%, and buying back notes at about A$89–91 per A$100 face [S1][S2].
  • Saunders defence contracts and Sydney Water panel volumes [S1].

Threats

  • The NCCGA coupon steps up to 5.5% from 30 Sep 2026 and 6.5% from 30 Sep 2027; at the 5.5% rate interest is about A$1.26m p.a. on A$22.83m face (analyst calculation) [S5].
  • Refinancing or repayment of about A$22.8m by 30 Sep 2028 against a portfolio of illiquid micro-caps [S5].
  • Rising rates: RBA cash rate 4.35% after +75 bp in FY26 [S1].
  • Level 3 valuation judgement on unlisted holdings is a Key Audit Matter [S1].
  • Software sector de-rating affects Pharmx and Comms Group peers [S1].
  • Investor preference for passive and scale vehicles keeps sub-scale LIC discounts wide [S1].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025Invitation to NAOS Q3 FY25 Investor Update [S11]Routine engagement
17 Apr 2025NAOS Quarterly Investment Report Q3 FY25 [S11]Portfolio commentary
24 Apr 2025FY25 interim dividend 2.00 cps paid (fully franked) [S1]Dividend maintained
3 Jul 2025Invitation to Q4 FY25 Investor Update [S11]Routine
30 Jul 2025Quarterly Investment Report Q4 FY25 [S11][S2]FY25 portfolio +5.59%
5 Aug 2025Q4 FY25 Investor Update presentation materials released [S11]Engagement
Aug 2025Investee HNG acquires Trutex Group [S1]Investee consolidation
14 Aug 2025NTA & Portfolio Update, July 2025 [S11]Routine disclosure
21 Aug 2025FY25 Appendix 4E & Annual Report; final dividend 2.00 cps declared [S1][S11]NPAT A$0.28m; post-tax NTA A$0.50
31 Oct 2025FY25 final dividend paid (A$1.48m) [S1]Cash return
Late CY25Decision to exit Ordermentum (completed in FY26) [S1]Portfolio simplification; capital redeployed
Jan 2026Investee Schoolblazer announces Kambala School as first Australian independent-school customer [S1]Thesis validation
27 Jan 2026Quarterly Investment Report Q2 FY26 [S11]Commentary
3 Feb 2026NAOS LIC investor presentation (shared NAOS materials) [S18]Engagement
Feb 2026Investee Pharmx enters strategic alliance with Sigma Healthcare (~10% stake; A$8.7m fee; 5-year renewal) [S1]Major de-risking of a core holding
19 Feb 2026Half-year results: PBT A$8.79m, NPAT A$7.67m; portfolio +18.56%; TSR +74.52%; net assets A$43.04m; interim dividend increased to 2.10 cps [S3]Inflection confirmed; first dividend rate increase since FY21
11 Mar 2026NTA & Portfolio Update, February 2026 [S11]Routine
12 Mar 2026NCCGA interest payment notice [S11]Debt service
24 Mar 2026Invitation to Q3 FY26 Investor Update [S11]Routine
25 Mar 2026Interim dividend ex-date [S3]—
13 Apr 2026NTA Update, March 2026: NCCGA notes on issue 229,295; note price A$85.10 [S12]Notes trading at a deep discount
23 Apr 2026Quarterly Investment Report Q3 FY26 [S11]Commentary (incl. software de-rating theme)
24 Apr 2026Interim dividend 2.10 cps paid (A$1.55m) [S1]Cash return
11 May 2026NTA Update, April 2026 [S11]Routine
11 Jun 2026NTA Update, May 2026; Update – Notification of buy-back (NCCGA) [S11]Note buy-back underway
24–25 Jun 2026Further NCCGA buy-back update notices [S11]Gearing reduction
29 Jun 2026Invitation to Q4 FY26 Investor Update [S11]Routine
14 Jul 2026NTA Update, June 2026 (FY26 +18.72%); Notification of buy-back (NCCGA) [S11][S17]Year-end performance
16 Jul 2026Update – Notification of buy-back (NCCGA) [S11]Continued capital management
Jul 2026Firmus Grid private funding round (per manager) [S1]Potential NTA uplift; the 4E subsequent event cites ~A$5.32m pre-tax for an unnamed unlisted investee
24 Jul 2026Quarterly Investment Report Q4 FY26 [S11]Commentary
7 Aug 2026Investment Manager renamed NAOS Asset Management Pty Ltd [S1]Manager restructure
12 Aug 2026NTA Update, July 2026: pre-tax NTA A$0.54, post-tax A$0.60; July return +8.75% [S2]Strong start to FY27
20 Aug 2026FY26 Appendix 4E & Annual Report; final dividend 2.10 cps declared [S1]NPAT A$7.14m; FY26 dividend 4.20 cps
17 Sep 2026Closing date for director nominations for the 2026 AGM [S1]Governance
30 Sep 2026NCCGA scheduled coupon step-up date (4.50% to 5.50%).Financing cost
8 Oct 2026Final dividend ex-date; NAOS Roadshow Perth [S1]—
12 Oct 2026Last date for DRP election [S1]—

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Revenue by Segment (%): Contribution to total income held from 100% in FY2024 to 100% in FY2026.
NAOS Emerging Opportunities Company Limited — Revenue by Segment (%)
Series (%)FY2024FY2025FY2026
Contribution to total income100100100

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.